Literature DB >> 1697425

Lack of natural antibodies in rheumatic diseases.

J W Bijlsma1, C Plater-Zyberk, P Mumford, R N Maini.   

Abstract

The prevalence and Ig class of natural antibodies in the sera of healthy individuals and of patients with rheumatic diseases were studied. The presence, even in high concentrations, of natural antibodies in normals was confirmed. In the rheumatic diseases tested, however, a discordance in the levels and Ig class of anti-actin, anti-myosin and anti-ssDNA antibodies was noted. IgM anti-actin antibodies occur infrequently, whereas IgM anti-myosin and anti-ssDNA are increased in these diseases. IgG anti-actin antibodies are increased in the sera of patients with RA, but not in patients with SLE, polymyositis or mixed connective tissue disease (MCTD). IgG anti-myosin as well as anti-ssDNA antibodies were increased in patients with RA and SLE, but not in patients with polymyositis or MCTD. These findings suggest that these natural antibodies are unlike the multispecific autoantibodies produced by lymphocytes from the CD5+ B cell lineage and that they may have undergone affinity maturation. Perhaps natural antibodies are a feature of health rather than of disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697425     DOI: 10.1007/bf02274824

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  24 in total

1.  Specificity of natural serum antibodies present in phylogenetically distinct fish species.

Authors:  R Gonzalez; J Charlemagne; W Mahana; S Avrameas
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

2.  Evidence for anti-tubulin autoantibodies in the form of immune complexes in human sera.

Authors:  F Bernier-Valentin; R Rabilloud; B Rousset
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

Review 3.  Autoimmunity in rheumatoid arthritis. An approach via a study of B lymphocytes.

Authors:  R N Maini; C Plater-Zyberk; E Andrew
Journal:  Rheum Dis Clin North Am       Date:  1987-08       Impact factor: 2.670

4.  Rheumatoid factor secretion from human Leu-1+ B cells.

Authors:  R R Hardy; K Hayakawa; M Shimizu; K Yamasaki; T Kishimoto
Journal:  Science       Date:  1987-04-03       Impact factor: 47.728

5.  Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset.

Authors:  P Casali; S E Burastero; M Nakamura; G Inghirami; A L Notkins
Journal:  Science       Date:  1987-04-03       Impact factor: 47.728

6.  Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies.

Authors:  K Hayakawa; R R Hardy; M Honda; L A Herzenberg; A D Steinberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

7.  Radioimmunoassay for antibodies to human skeletal muscle myosin in serum from patients with polymyositis.

Authors:  K Wada; S Ueno; T Hazama; S Ogasahara; J Kang; M Takahashi; S Tarui
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

8.  Human monoclonal rheumatoid factor-like antibodies from CD5 (Leu-1)+ B cells are polyreactive.

Authors:  M Nakamura; S E Burastero; A L Notkins; P Casal
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

9.  Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia.

Authors:  F Caligaris-Cappio; M Gobbi; M Bofill; G Janossy
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

10.  Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease.

Authors:  D Koffler; R Carr; V Agnello; R Thoburn; H G Kunkel
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

View more
  2 in total

Review 1.  The clinical and diagnostic significance of anti-myosin autoantibodies in cardiac disease.

Authors:  Udi Nussinovitch; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

2.  A confocal microscopy study of anticytoskeletal antibody activity in patients with connective tissue disease.

Authors:  P W French; R Penny; J L Yang
Journal:  Clin Diagn Lab Immunol       Date:  1994-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.